A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Clinical trial NCT05363605 · TERMINATED

Trial details

NCT number: NCT05363605
Sponsor: Fusion Pharmaceuticals Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Head and Neck Squamous Cell Carcinoma Bladder Carcinoma Susceptible FGFR3 Genetic Alterations FGFR3 FGFR3 Overexpression FGFR3 Receptor FGFR3 Protein Overexpression Ovarian Cancer Colorectal Cancer Breast Cancer Liver Cancer

Start date: 2022-04-20
Primary completion: 2023-09-08
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.